Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 1, 2026

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
06:06

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint

Published on: July 22, 2021

Transcriptome analysis in osteoarthritis primary tissues identifies high-confidence effector genes.

Georgia Katsoula1,2, Ana Luiza Arruda2,3, Mauro Tutino2

  • 1Technical University of Munich (TUM), TUM University Hospital, TUM School of Medicine and Health, Munich, Germany.

Nature Communications
|June 29, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026
Same author

Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model.

European heart journal·2026
Same author

The causal association between sleep traits and osteoarthritis traits: evidence from bidirectional mendelian randomization.

Human molecular genetics·2026
Same author

Multi-ancestry, trans-generational GWAS meta-analysis of gestational diabetes and glycaemic traits during pregnancy reveals limited evidence of pregnancy-specific genetic effects.

Nature communications·2026
Same author

Publisher Correction: Multi-ancestry genome-wide association analyses of refractive error augment genetic discovery and polygenic prediction.

Nature genetics·2026
Same author

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Bone & joint open·2026
This summary is machine-generated.

This study maps gene regulation in osteoarthritis tissues, identifying novel genetic links and potential drug targets like LGALS3 and SMAD7 for this widespread joint disorder.

Area of Science:

  • Genomics
  • Molecular Biology
  • Rheumatology

Background:

  • Osteoarthritis is a degenerative joint disease affecting 600 million people globally.
  • Current treatments manage symptoms, lacking disease modification.
  • Understanding molecular mechanisms is key to developing new therapies.

Purpose of the Study:

  • To create a comprehensive map of gene regulation in osteoarthritis-relevant tissues.
  • To identify genetic variants influencing osteoarthritis risk and gene expression.
  • To discover potential therapeutic targets for osteoarthritis.

Main Methods:

  • Generated expression quantitative trait loci (eQTL) maps from knee cartilage, synovium, and fat pad tissues.
  • Integrated eQTL data with the largest osteoarthritis genome-wide association study (GWAS).

Related Experiment Videos

Last Updated: Jul 1, 2026

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
06:06

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint

Published on: July 22, 2021

  • Utilized functional genomics to delineate regulatory architectures of risk variants.
  • Main Results:

    • Identified 10,166 unique eQTL-associated genes, with 61.1% being novel in osteoarthritis.
    • Discovered cartilage grade-specific genetic regulation.
    • Prioritized 45 high-confidence effector genes, revealing altered expression of chondrogenic and hypertrophic signaling pathways.

    Conclusions:

    • Osteoarthritis genetic risk is linked to dysregulated chondrogenic and hypertrophic pathways.
    • Drug repurposing opportunities exist for LGALS3 and SMAD7 in osteoarthritis treatment.
    • This research provides a foundation for precision medicine approaches in osteoarthritis.